(Q44673846)

5 December 2017

title

Pharmacokinetics of single and multiple doses of phenytoin in man (English)

1 reference

12 March 2023

1 reference

1 reference

12 March 2023

1 reference

L. Lund

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4853604

12 March 2023

G. Alvan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4853604

12 March 2023

A. Berlin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4853604

12 March 2023

B. Alexanderson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4853604

12 March 2023

language of work or name

1 reference

1 January 1974

1 reference

full work available at URL

5 December 2017

http://link.springer.com/content/pdf/10.1007/BF00561319.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00561319/fulltext.html

12 March 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00561319

12 March 2023

1 reference

European Journal of Clinical Pharmacology

12 March 2023

published in

1 reference

5 December 2017

volume

7

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

81-86

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00561319

5 December 2017

exact match

0 references

cites work

Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00561319

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00561319

The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)

21 January 2018

1 reference

12 December 2020

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding

1 reference

12 December 2020

The effect of phenyramidol on the metabolism of diphenylhydantoin

1 reference

12 December 2020

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

1 reference

12 December 2020

Outbreak of Anticonvulsant Intoxication in an Australian City

1 reference

12 December 2020

Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin

1 reference

12 December 2020

Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy

1 reference

12 December 2020

Micromethod for the Determination of Diphenylhydantoin in Plasma and Cerebrospinal Fluid—A Comparison Between a Gas Chromatographic and a Spectrophotometric Method

1 reference

12 December 2020

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation

1 reference

12 December 2020

Dicoumarol-induced diphenylhydantoin intoxication

1 reference

12 December 2020

Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data

1 reference

12 December 2020

Blood Levels of Drug at the Equilibrium State after Multiple Dosing

1 reference

12 December 2020

Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.

1 reference

12 December 2020

The rate of decline of diphenylhydantoin in human plasma

1 reference

12 December 2020

Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man

1 reference

12 December 2020

A pharmacokinetic approach to the treatment of depression

1 reference

12 December 2020

The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine

1 reference

12 December 2020

Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.

1 reference

12 December 2020

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

1 reference

12 December 2020

Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro

1 reference

12 December 2020

Dose-dependence of drug plasma level decline in dogs

1 reference

12 December 2020

Supervision of epileptic patients taking phenytoin.

1 reference

12 December 2020

Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man

1 reference

12 December 2020

SERUM DIPHENYLHYDANTOIN (PHENYTOIN) IN AMBULANT PATIENTS WITH EPILEPSY.

1 reference

12 December 2020

9

10

167

C.M. Martin

1968

1 reference

Journal of Pharmacology and Experimental Therapeutics

12 March 2023

13

158

305

P.G. Dayton

1967

1 reference

Journal of Pharmacology and Experimental Therapeutics

12 March 2023

16

178

567

N. Gerber

1971

1 reference

Journal of Pharmacology and Experimental Therapeutics

12 March 2023

31

118

270

W.A. Dill

1956

1 reference

12 March 2023

Identifiers

DOI

10.1007/BF00561319

1 reference

5 December 2017

1 reference